<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Another Quarter of Healthy Growth: Q121 Trauma Market Recap

By Natasha Weeks on 6/11/21 9:30 AM

Inclement weather, strong product performances and the impact of M&A all help to drive another quarter of healthy growth for the Trauma Market.

The Trauma Market experienced the third sequential quarter of increasingly healthy growth as both the WW and US Trauma Markets were up YoY. New product introductions, along with inclement weather in the US and EU drove trauma procedures during the first quarter of 2021.

During the Stryker Q121 earnings call, management noted that their trauma business, which is less elective in nature, benefited from inclement weather in the US and Europe in February. 

Among the many topics covered in detail in our comprehensive Q121 Trauma Market Recap* are:

Topics: Orthopedics
Continue Reading
2 min read

Back on Track: Q121 Extremities Market Recap

By Lisa Mahan on 6/10/21 9:30 AM

The first quarter of 2021 sees a resurgence of procedures and new product introductions as M&A activity abounds signaling that the Extremities Market is back on track.

Inclement weather, the return of elective procedures and new product introductions all contributed to growth in the WW Extremities Market, up +5.1% in Q121 and the US market seeing even higher growth. M&A activity continues to impact the Extremities segment as companies expand their portfolios and work to synergize product development and commercial efforts.

Among the many topics covered in detail in our comprehensive   Q121 Extremities Market Recap *  are:
Topics: Orthopedics
Continue Reading
2 min read

COVID-19 & Revision Knee Procedures: An Interview with Craig Della Valle, MD

By Lisa Mahan on 6/8/21 10:50 AM

In Q420 and into Q121, COVID-19 cases ramped up in the US, impacting US Knee replacement procedures. Several large implant manufacturers reported seeing hip procedures being prioritized over knee replacement cases given their more elective nature. However, revision knee replacements are not always able to be postponed. Craig Della Valle, MD of Midwest Orthopaedics at Rush in Chicago discusses the effects of COVID-19 on revision knee procedures and the changes to care pathways precipitated by the pandemic.

To listen to the interview, recorded live via Zoom, click on the following video. A link to the transcript of the interview is also provided below.

Continue Reading
2 min read

Picking Up Speed: Q121 Arthroscopic Technologies Market Recap

By Andy Knapik on 6/4/21 11:22 AM

Arthroscopic Technologies starts to pick up speed in 2021

While the COVID pandemic was still slowing parts of the overall medical device market, the Arthroscopic Technologies market was able to start to pull ahead as case volumes for Arthroscopic Sports Medicine procedures started to climb back towards pre-COVID levels.

Among the many topics covered in detail in our comprehensive   Q121 Arthroscopics Technologies Market Recap *  are:
Topics: Orthopedics
Continue Reading
2 min read

A Tale of Two Recoveries: US Hemostats & Sealants Q121 Market Recap

By Doug Devens on 6/3/21 9:30 AM

The US market for Hemostats and Sealants resumed its growth in Q121 as procedures climbed back towards normal.

While surgical procedures have not fully regained their pre-COVID levels, the US Hemostats and Sealants market grew in Q121 according to SmartTRAK Financial Dashboard. However, it continued to be a tale of two recoveries. CryoLife* and especially JNJ/Ethicon* posted solid gains for the quarter. However, as elective procedures continue to be behind pre-COVID levels, other manufacturers lagged by comparison.

Among the many topics covered in detail in our comprehensive   Q121 Hemostats and Sealants Market Recap *  are:
Topics: Wound Care
Continue Reading
2 min read

A Ray of Sunshine: Q121 Total Joints Market Recap

By Lisa Mahan on 6/1/21 11:16 AM

COVID surges dampened procedure volumes in early Q121, but recovery late in the quarter was like a ray of sunshine

Early in 2021, the dark cloud of the COVID-19 resurgence that started in late 2020 continued to loom over the market early in the quarter. Med tech companies and healthcare providers reported procedure volumes being dampened, but with rays of sunshine peeking through late February and early March. During their Q121 earnings call, HCA Healthcare, one of the largest hospital and healthcare systems in the US, reported rebounding surgical and outpatient volumes in March, with outpatient surgery revenues increasing 30%.

Topics: Orthopedics
Continue Reading
5 min read

SAWC 2021: What's New in Advanced Wound Care?

By Susan Paquette on 5/24/21 1:37 PM

The Symposium on Advanced Wound Care, SAWC, the official meeting of the Wound Healing Society, was held virtually May 10-14 and SmartTRAK attended.

Following is a sampling of some of the takeaways from the meeting that were gathered and curated by our expert analysts and sent out to subscribers in our Daily Updates.

S&N featured a session introducing STRAVIX PL, lyopreserved umbilical tissue w/ room temperature storage, while also highlighting GRAFIX PL, GRAFIX and STRAVIX. SAWC Virtual 2021

A 981-pt (1,111-VLUs) non-inferiority, comparative effectiveness study of PuraPly AM (collagen matrix plus PHMB) antimicrobial and Theraskin (cryopreserved cadaveric skin allograft) for use in VLUs found wound closure comparable at 8, 12, 18 and 24 wks.  SAWC Virtual 2021 CR-17

LifeNet*
LifeNet featured Dermacell AWM and recently launched Matrion at SAWC. Matrion is a human placental allograft used as a barrier membrane to treat chronic and acute wounds – a naturally intact placental membrane to incorporate the full trophoblast layer. SAWC Virtual 2021

Find out how to receive SmartTRAK Daily Updates in your morning email

Topics: Wound Care
Continue Reading
2 min read

Light at the End of the Tunnel: Q121 Soft Tissue Fixation Market Recap

By Andy Knapik on 5/24/21 12:00 PM

COVID roadblocks persist, but the path may be clearing for Soft Tissue Fixation

While COVID was still causing roadblocks for the overall medical device market, Soft Tissue Fixation was able to see some light at the end of the tunnel as case volumes for Orthopedic Sports Medicine procedures started to climb back towards pre-COVID levels.

Q1 Soft Tissue Fixation saw positive revenue growth across all segments over the previous year, especially towards the end of the quarter where case volumes started to pick back up compared to the same period last year, when case volumes plummeted due to the start of the COVID pandemic.

Among the many topics covered in the comprehensive Q121 Soft Tissue Fixation Market Recap* are:

Topics: Orthopedics
Continue Reading
6 min read

What's New at Depuy Synthes?

By Thomas Wallick on 5/18/21 9:06 AM

SmartTRAK highlights what’s new in orthopedics, sports medicine, wound care, regenerative medicine and neuro therapies, with a spotlight on Depuy Synthes, a subsidiary of J&J. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, patents, research, financial data and competitor developments in the global life sciences industry.

The following is a sampling of some recent updates covering Depuy Synthes that were compiled, reviewed and posted in real-time by our SmartTRAK analysts.

New Products:

  • DePuy Synthes will distribute Expanding Innovations’ X-Pac Expandable Lumbar Cage System in the US. The system allows for controlled expansion of both height and lordosis and post-packing of graft.
  • In its Q420 earnings call, JNJ touted the FDA clearance of its VELYS Robotic-Assisted Solution for use w/ the ATTUNE* knee system. The Company will launch its VELYS robot for TKA in 2021, however, specific timing was not provided. JNJ Q420 Earnings Transcript on Seeking Alpha
  • WFS analyst Larry Biegelsen notes that in addition to competitive advantages including small footprint, digital connectivity, short set-up time & small learning curve, JNJ’s VELYS robot is expected to be cost-effective w/ prior commentary suggesting a price point of ~$250K.

    Find out how to receive SmartTRAK Daily Updates in your morning email
Continue Reading
2 min read

Do You Know What Your Competition is Up to?

By Thomas Wallick on 5/17/21 11:16 AM

Sure you read the news, a blog or journal or two, but you do you ever truly feel like you know what your competition is up to? SmartTRAK does! We provide real-time market intel on the MedTech industry including trends, news, financial data, competitor developments and more.  Our platform is fueled by industry experts, all of whom have had years of previous experience working at some of the biggest players in the industry.  Our team knows what's important to you and we keep our eye to the competition 24/7-- so that our subscribers can save time and find all the competitive intel they need in one place.

SmartTRAK currently features profiles on an ever-growing growing list of over 7,000+ products, including product descriptions, classifications, indications, clinical updates, regulatory status, studies, reimbursements, sales and distribution and more. Learn more about SmartTRAK's competitor profiling below:


SmartTRAK
also provides up-to-date, detailed company overviews, including the latest intel, revenues and financial outlooks, strategic alliances and more on over 1,100+ companies, and the list is growing daily. New to a particular industry, or looking to expand into new territory? SmartTRAK's company and product profiles can help you get the lay of the land quickly:

 

A subscription to SmartTRAK provides you with access to our comprehensive coverage of Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapies markets worldwide. In addition, all subscribers receive a Daily Updates email containing the latest need-to-know news curated by our expert analysts. It's the perfect way to start your day! If you would like to learn more about   SmartTRAK , or to see if your company subscribes, just click the button below.

Learn More

Continue Reading

    Recent Articles